Early cancer detection significantly improves outcomes, but many diagnostic tools lack the sensitivity to identify disease at its earliest stages. Single analyte assays often fall short because tumor development involves complex networks of interacting biomarkers that cannot be captured by one marker alone.
Multiplex immunoassays overcome this limitation by measuring multiple biomarkers simultaneously from small sample volumes. This approach provides system level insight into subtle biological changes linked to early tumor formation.
Download this guide to explore:
- How to meet the challenges of early cancer detection
- The 6 core benefits of protein biomarkers
- Multiplexed detection of tumor biomarker proteins
- The vital role of multiplex immunoassays
